Abstract:The development of small molecules that can bind and recognize DNA with sequence- or stereo-specificity under physiological conditions has been attracting a great interest in chemistry and biochemistry. Here, spectroscopic characterization and gel electrophoresis methods have been utilized to investigate the DNA binding and recognition by a variety of binuclear transition metal complexes. The results indicate that the structures and charges of binuclear transition metal complexes, compositions of coordination spheres, central metal ions and their coordination unsaturation, and separations between two central metal atoms can exert significant effects on the DNA binding and recognition. If there are not intercalative ligands into DNA base pairs or kinetically substitutable ligands by DNA phosphate groups within coordination sphere, the coordination saturation and compact binuclear transition metal complexes weaker bind to DNA than the coordination unsaturation and extended ones to DNA. Since the different transition metal ions exhibit different affinities to DNA phosphate oxygen atoms, the binding interactions between their binuclear complexes and DNA are controlled by the affinity. The binuclear complexes with one or more negative charges lead to a consequence that they can not efficiently associate with DNA, because DNA phosphodiester backbone is negatively charged. When the separations between two central transition metal atoms is more than the distance between two DNA base pairs (0.34nm), the binuclear complexes could bind and recognize the DNA sequence with two or more base pairs. The protonated and positively charged ligands can strengthen the DNA binding and recognition by these binuclear metal complexes. Based on such DNA binding and recognition principles, the binuclear zinc complex designed in the study preferentially bind and recognize the following DNA sequence on pBR322 DNA with binding constant K=(2.6 +/-0.2)x10(5) M. TTC C TT TTG CCT T CCTTT CT CC C TT TTCC T T TT T, AAGGAA AACGGAA GGAAAGAGGGAA AAGGAAAAA.

Selective binding of small molecules to DNA: application and perspectives.

Enabling Programmable Dynamic DNA Chemistry Using Small-Molecule DNA Binders

DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action

Binding of Anticancer Drug Daunomycin to a TGGGGT G-quadruplex DNA Probed by All-Atom Molecular Dynamics Simulations: Additional Pure Groove Binding Mode and Implications on Designing More Selective G-quadruplex Ligands

Insight into the Selective Binding Mechanism of DNMT1 and DNMT3A Inhibitors: a Molecular Simulation Study.

X-ray Structure Characterization of the Selective Recognition of AT Base Pair Sequences

Review on DNA Minor Groove Binders As Antitumor Drugs

DNA Nanotechnology-Facilitated Ligand Manipulation for Targeted Therapeutics and Diagnostics.

An Analysis Method for Simultaneous Screening of Deoxyribonucleic Acid-Binding Active Compounds and Investigating Their Mechanisms by Ultra-Fast Liquid Chromatography Tandem Mass Spectrometry Coupled with Fluorescence Detection Technology.

DNA G-quadruplex Binders: a Patent Review

Diversity of DNA Nanostructures and Applications in Oncotherapy

Advances in intelligent DNA nanomachines for targeted cancer therapy

DNA Nanotechnology‐Based Biosensors and Therapeutics

Binding to the DNA Minor Groove by Heterocyclic Dications: from AT Specific to GC Recognition Compounds

Dna Binding and Recognition by Binuclear Transition Metal Complexes

Aptamer-Integrated Dna Nanostructures For Biosensing, Bioimaging And Cancer Therapy

DNA Methyltransferases: Emerging Targets for the Discovery of Inhibitors As Potent Anticancer Drugs

Dna-Encoded Dynamic Chemical Library And Its Applications In Ligand Discovery

Recent Advances in DNA Nanomaterials for Cancer Diagnosis and Treatment

Screening the sequence selectivity of DNA-binding molecules using a gold nanoparticle-based colorimetric approach.

Designer DNA Nanostructures for Therapeutics